宣肺化痰汤加减联合西药治疗慢性阻塞性肺疾病急性加重期临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:


Clinical Study on Modified Xuanfei Huatan Decoction Combined with Western Medicine for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察宣肺化痰汤加减联合西药治疗慢性阻塞性肺疾病急性加重期(AECOPD) 痰浊蕴肺证 的临床效果。方法:以随机数字表法将124例AECOPD痰浊蕴肺证患者分为观察组(以宣肺化痰汤加减联合西 药治疗) 和对照组(仅以西药治疗),每组62例。2组均治疗2周后评估临床疗效、中医证候积分、肺功能指 标及炎症指标水平。结果:治疗2周后,总有效率观察组95.16%,高于对照组83.87%(P<0.05)。中医证候积 分2组均低于治疗前(P<0.05),且观察组低于对照组(P<0.05)。第1秒用力呼气容积(FEV1)、用力肺活 量(FVC)、FEV1/FVC、第1秒用力呼气容积占预计值的百分比(FEV1%pred) 2组均高于治疗前(P<0.05), 且观察组上述4项肺功能指标值均高于对照组(P<0.05)。血清超敏C-反应蛋白(hs-CRP)、白细胞介素- 6(IL-6) 及肿瘤坏死因子-α(TNF-α) 水平2组均低于治疗前(P<0.05),且观察组上述3项炎症指标水平均 低于对照组(P<0.05)。结论:宣肺化痰汤加减联合西药治疗AECOPD痰浊蕴肺证疗效显著,可有效改善临床 症状、肺功能及炎症指标。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Xuanfei Huatan Decoction combined with western medicine on patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with syndrome of turbid phlegm accumulation in the lung. Methods: A total of 124 cases of AECOPD patients with syndrome of turbid phlegm accumulation in the lung were randomly divided into the observation group (treated with modified Xuanfei Huatan Decoction combined with western medicine) and the control group (treated with western medicine only), with 62 cases in each group. After two weeks of treatment,both groups were evaluated for clinical effects,traditional Chinese medicine (TCM) syndrome scores, lung function indicators, and serum inflammatory index levels. Results: After two weeks of treatment, the total effective rate in the observation group was better than that in the control group (95.16% vs 83.87%) (P<0.05). The TCM syndrome scores in both groups were lower than those before treatment (P<0.05),and the TCM syndrome scores in the observation group were lower than those in the control group (P<0.05). The forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC,and the percentage of FEV1 to the expected value (FEV1%pred) in both groups were higher than those before treatment (P<0.05);the above four indexes in the observation group were higher than those in the control group (P<0.05). The levels of serum high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor- α (TNF- α) were all lower than those before treatment (P< 0.05), and the levels of the above three indicators in the observation group were lower than those in the control group (P<0.05). Conclusion: The combination of modified Xuanfei Huatan Decoction and western medicine has a significant therapeutic effect on AECOPD patients with syndrome of turbid phlegm accumulation in the lung,which has a positive improvement effect on clinical symptoms,lung function and inflammatory indicator.

    参考文献
    相似文献
    引证文献
引用本文

全燕燕,朱景倩,马正兴,杜旦锋.宣肺化痰汤加减联合西药治疗慢性阻塞性肺疾病急性加重期临床研究[J].新中医,2024,56(14):75-79

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-07-28
  • 出版日期:
文章二维码